Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain - Concepedia

Concepedia

Publication | Open Access

Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain

DOI Full Paper Access

22

Citations

12

References

2024

Year

Clara Mazagatos, Jacobo Mendioroz, Mercedes Rumayor, Virtudes Gallardo García, Virginia Álvarez Río, Ana Delia Cebollada Gracia, Noa Batalla Rebollo, María Isabel Barranco Boada, Olaia Pérez‐Martínez, A. Azevedo,

Influenza and Other Respiratory Viruses

Abstract

We estimated 9364-9875 RSV hospitalisations less than expected, corresponding to a 74%-75% reduction.

References

	Year	Citations

Page 1